0001209191-20-044360.txt : 20200731 0001209191-20-044360.hdr.sgml : 20200731 20200731210518 ACCESSION NUMBER: 0001209191-20-044360 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200107 FILED AS OF DATE: 20200731 DATE AS OF CHANGE: 20200731 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BREITMEYER JAMES B CENTRAL INDEX KEY: 0001244823 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 201067596 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2020-01-07 2020-01-09 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001244823 BREITMEYER JAMES B 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Stock Option 22000.00 2020-01-07 4 A 0 22000 0.00 A 2030-01-07 Common Stock 22000 22000 I By Spouse The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5. The options generally vest as follows: 25% of the total number of shares subject to the options shall vest on the first anniversary of the vesting commencement date and 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of the vesting commencement date thereafter, subject to the option recipient's continuous service to the Corporation on each such vesting date, so that the options shall be fully vested on the forth anniversary of the vesting commencement date. 22,000 Stock Options granted to Mary Breitmeyer with a January 7,2020 transaction date . /s/ Hazel M. Aker, Attorney-in-fact 2020-07-31